Results 211 to 220 of about 39,893 (252)

Vasomotor Symptoms

2014
Maria Celeste O. Wender, Patrícia Pereira de Oliveira   +1 more
openaire   +2 more sources

Hormone therapy and vasomotor symptoms

Menopause, 2011
Pauliina, Tuomikoski, Tomi S, Mikkola, Olavi, Ylikorkala   +2 more
openaire   +2 more sources

Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study

Lancet, The, 2023
Faith Ottery, Nanette Santoro, Marci English   +2 more
exaly  

Vasomotor Symptoms

2021
openaire   +1 more source

Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial

Lancet, The, 2022
Amanda Vrselja, Rodney Baber, Bronwyn G A Stuckey   +2 more
exaly  

Vasomotor Symptoms

Obstetrics & Gynecology, 2004
openaire   +2 more sources

Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT

Journal of Clinical Endocrinology and Metabolism, 2023
genevieve neal-perry, Petra Stute, Rebecca C Thurston   +2 more
exaly  

Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN

Journal of the American Heart Association, 2021
Rebecca C Thurston, Carol A Derby, Hadine Joffe   +2 more
exaly  

Treatment of menopausal vasomotor symptoms.

The Medical letter on drugs and therapeutics, 2005
The Women's Health Initiative finding that taking estrogen plus a progestin for more than five years increased the risk of cardiovascular disease and breast cancer left the safety of using estrogen to treat hot flashes open to question. How low a dose and how short a duration would be safe and effective are unknown.
openaire   +3 more sources

Vasomotor Symptoms

Journal of Obstetrics and Gynaecology Canada, 2009
openaire   +1 more source